Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4415-4421

  Li, Xiangming ^a   Shiratsuchi, Takayuki ^a   Chen, Guangwu ^b   Dellabona, Paolo ^c   Casorati, Giulia ^c   Franck, Richard W ^b   Tsuji, Moriya ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; GCK 127; GCK 152; GLYCOLIPID; GLYCOSIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ALPHA GALACTOSYLCERAMIDE; ALPHA-GALACTOSYLCERAMIDE; C GLYCOSIDE; C-GLYCOSIDE; CD1D PROTEIN, HUMAN; GALACTOSYLCERAMIDE; LYMPHOCYTE ANTIGEN RECEPTOR; MONOSACCHARIDE; VALPHA24 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; CARBOHYDRATE ANALYSIS; CELL DIFFERENTIATION; CELL LINE; COCULTURE; COMPARATIVE STUDY; DRUG EFFECT; GENE REARRANGEMENT; GENETICS; HELA CELL; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SPECIES DIFFERENCE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1D; CARBOHYDRATE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; COCULTURE TECHNIQUES; FEMALE; GALACTOSYLCERAMIDES; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MONOSACCHARIDES; NATURAL KILLER T-CELLS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; SPECIES SPECIFICITY;

EID: 70449730935     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901021     Document Type: Article

References (27)

1. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
2. Tsuji, M. 2006. Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands. Cell. Mol. Life. Sci. 63: 1889-1898.
3. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
4. Chen, X., X. Wang, G. S. Besra, and J. E. Gumperz. 2007. Modulation of CD1d-restricted NKT cell responses by CD4. J. Leukocyte Biol. 82: 1455-1465. (Pubitemid 350276957)
5. Fujio, M., D. Wu, R. Garcia-Navarro, D. D. Ho, M. Tsuji, and C. H. Wong. 2006. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity. J. Am. Chem. Soc. 128: 9022-9023.
6. Goff, R. D., Y. Gao, J. Mattner, D. Zhou, N. Yin, C. Cantu, 3rd, L. Teyton, A. Bendelac, and P. B. Savage. 2004. Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells. J. Am. Chem. Soc. 126: 13602-13603.
7. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534. (Pubitemid 32938752)
8. Li, X., G. C., R. Garcia-Navarro, R. W. Franck, and M. Tsuji. 2009. Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells. Immunology 127: 216-225.
9. Chen, G., M. Chien, M. Tsuji, and R. W. Franck. 2006. E and Z α-C-galactosylceramides by Julia-Lythgoe-Kocienski chemistry: a test of the receptor-binding model for glycolipid immunostimulants. Chembiochemistry 7: 1017-1022.
10. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525. (Pubitemid 40477061)
11. + invariant NKT cells. Blood 110: 251-258.
12. Watarai, H., R. Nakagawa, M. Omori-Miyake, N. Dashtsoodol, and M. Taniguchi. 2008. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat. Protocol. 3: 70-78.
13. Molling, J. W., M. Moreno, H. J. van der Vliet, B. M. von Blomberg, A. J. van den Eertwegh, R. J. Scheper, and H. J. Bontkes. 2007. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity. J. Immunol. Methods 322: 70-81.
14. Mandal, M., X. R. Chen, M. L. Alegre, N. M. Chiu, Y. H. Chen, A. R. Castano, and C. R. Wang. 1998. Tissue distribution, regulation and intracellular localization of murine CD1 molecules. Mol. Immunol. 35: 525-536.
15. Rauch, J., J. Gumperz, C. Robinson, M. Skold, C. Roy, D. C. Young, M. Lafleur, D. B. Moody, M. B. Brenner, C. E. Costello, and S. M. Behar. 2003. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278: 47508-47515.
16. Sidobre, S., K. J. Hammond, L. Benazet-Sidobre, S. D. Maltsev, S. K. Richardson, R. M. Ndonye, A. R. Howell, T. Sakai, G. S. Besra, S. A. Porcelli, and M. Kronenberg. 2004. The T cell antigen receptor expressed by Vα14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. USA 101: 12254-12259.
17. Liang, P. H., M. Imamura, X. Li, D. Wu, M. Fujio, R. T. Guy, B. C. Wu, M. Tsuji, and C. H. Wong. 2008. Quantitative microarray analysis of intact glycolipid- CD1d interaction and correlation with cell-based cytokine production. J. Am. Chem. Soc. 130: 12348-12354.
18. Koch, M., V. S. Stronge, D. Shepherd, S. D. Gadola, B. Mathew, G. Ritter, A. R. Fersht, G. S. Besra, R. R. Schmidt, E. Y. Jones, and V. Cerundolo. 2005. The crystal structure of human CD1d with and without α-galactosylceramide. Nat. Immunol. 6: 819-826.
19. Zajonc, D. M., C. Cantu, 3rd, J. Mattner, D. Zhou, P. B. Savage, A. Bendelac, I. A. Wilson, and L. Teyton. 2005. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6: 810-818.
20. Borg, N. A., K. S. Wun, L. Kjer-Nielsen, M. C. Wilce, D. G. Pellicci, R. Koh, G. S. Besra, M. Bharadwaj, D. I. Godfrey, J. McCluskey, and J. Rossjohn. 2007. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448: 44-49.
21. Wun, K. S., N. A. Borg, L. Kjer-Nielsen, T. Beddoe, R. Koh, S. K. Richardson, M. Thakur, A. R. Howell, J. P. Scott-Browne, L. Gapin, D. I. Godfrey, J. McCluskey, and J. Rossjohn. 2008. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J. Exp. Med. 205: 939-949.
22. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
23. Silk, J. D., M. Salio, B. G. Reddy, D. Shepherd, U. Gileadi, J. Brown, S. H. Masri, P. Polzella, G. Ritter, G. S. Besra, et al. 2008. Cutting edge: non-glycosidic CD1d lipid ligands activate human and murine invariant NKT cells. J. Immunol. 180: 6452-6456.
24. Parekh, V. V., A. K. Singh, M. T. Wilson, D. Olivares-Villagomez, J. S. Bezbradica, H. Inazawa, H. Ehara, T. Sakai, I. Serizawa, L. Wu, et al. 2004. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids. J. Immunol. 173: 3693-3706.
25. Godfrey, D. I., J. McCluskey, and J. Rossjohn. 2005. CD1d antigen presentation: treats for NKT cells. Nat. Immunol. 6: 754-756.
26. Liu, Y., R. D. Goff, D. Zhou, J. Mattner, B. A. Sullivan, A. Khurana, C. Cantu, 3rd, E. V. Ravkov, C. C. Ibegbu, J. D. Altman, et al. 2006. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312: 34-39.
27. Pellicci, D. G., O. Patel, L. Kjer-Nielsen, S. S. Pang, L. C. Sullivan, K. Kyparissoudis, A. G. Brooks, H. H. Reid, S. Gras, I. S. Lucet, et al. 2009. Differential recognition of CD1d-α-galactosyl ceramide by the V β 8.2 and V β 7 semi-invariant NKT T cell receptors. Immunity 31: 47-59.